Characterization of cis-acting sequences involved in packaging porcine adenovirus type 3

Virology

Volumn 314, Issue 2, 2003, Pages 650-661

  Xing, Li ^a   Tikoo, Suresh Kumar ^a,b  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

^b UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; VIRUS DNA;

ADENOVIRUS; ARTICLE; DELETION MUTANT; DNA PACKAGING; DNA SEQUENCE; GENOME; HUMAN; HUMAN ADENOVIRUS 5; LONG TERMINAL REPEAT; NONHUMAN; PORCINE ADENOVIRUS; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN DOMAIN; PROTEIN MOTIF; VIRUS GENE; VIRUS MUTANT;

ADENOVIRIDAE; CANINE ADENOVIRUS; CHICKEN ANEMIA VIRUS; HUMAN ADENOVIRUS; HUMAN ADENOVIRUS TYPE 2; HUMAN ADENOVIRUS TYPE 3; HUMAN ADENOVIRUS TYPE 5; PORCINE ADENOVIRUS; PORCINE ADENOVIRUS 3; SUIDAE;

EID: 0141794402     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0042-6822(03)00493-8     Document Type: Article

References (55)

1. Balague C., Zhou J., Dai Y., Alemany R., Josephs S.F., Andreason G., Hariharan M., Sethi E., Prokopenko E., Jan H.Y., Lou Y.C., Hubert-Leslie D., Ruiz L., Zhang W.W. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood. 95:2000;820-828.
2. Bruder J.T., Hearing P. Nuclear factor EF-1A binds to the adenovirus E1A core enhancer element and to other transcriptional control regions. Mol. Cell Biol. 9:1989;5143-5153.
3. Chartier C., Degryse E., Gantzer M., Dieterle A., Pavirani A., Mehtali M. Efficient generation of recombinant adenovirus vectors by homologous recombination in Escherichia coli. J. Virol. 70:1996;4805-4810.
4. Chen H.-H., Mack L.M., Kelly R., Ontell M., Kochanek S., Clemens P.R. Persistence in muscle of an adenoviral vector that lacks all viral genes. Proc. Natl. Acad. Sci. USA. 94:1997;1645-1650.
5. Clarke M.C., Sharpe H.B., Derbyshire J.B. Some characteristics of three porcine adenoviruses. Arch. Gesamte Virusforsch. 21:1967;91-97.
6. Cregan S.P., MacLaurin J., Gendron T.F., Callaghan S., Park D.S., Parks R.J., Graham F.L., Morley P., Slack R.S. Helper-dependent adenovirus vectors their use as a gene delivery system to neurons . Gene Ther. 14:2000;1200-1209.
7. Daniell E. Genome structure of incomplete particles of adenovirus. J. Virol. 19:1976;685-708.
8. Derbyshire J.B., Clarke M.C., Collins A.P. Serological and pathogenicity studies with some unclassified porcine adenoviruses. J. Comp. Pathol. 85:1975;437-443.
9. D'Halluin J.C., Martin G.R., Torpier G., Boulanger P.A. Adenovirus type 2 assembly analyzed by reversible cross-linking of labile intermediates. J. Virol. 26:1978;357-363.
10. D'Halluin J.C., Milleville M., Boulanger P.A., Martin G.R. Temperature-sensitive mutant of adenovirus type 2 blocked in virion assembly accumulation of light intermediate particles . J. Virol. 26:1978;344-356.
11. D'Halluin J.C., Milleville M., Martin M.R., Boulanger P. Morphogenesis of human adenovirus type 2 studied with fiber- and fiber and penton base-defective temperature-sensitive mutants. J. Virol. 33:1980;88-99.
12. D'Halluin J.C. Virus assembly. Curr. Top. Microbiol. Immunol. 199:1995;47-66.
13. Edvardsson B., Everitt E., Jornvall H., Prage L., Philipson L. Intermediates in adenovirus assembly. J. Virol. 19:1976;533-547.
14. Edvardsson B., Ustacelebi S., Williams J., Philipson L. Assembly intermediates among adenovirus type 5 temperature-sensitive mutants. J. Virol. 25:1978;641-651.
15. Fujisawa H., Hearing P. Structure, function and specificity of the DNA packaging signals in double-stranded DNA viruses. Semin. Virol. 5:1994;5-13.
16. Grable M., Hearing P. Adenovirus type 5 packaging domain is composed of a repeated element that is functionally redundant. J. Virol. 64:1990;2047-2056.
17. Grable M., Hearing P. cis and trans requirements for the selective packaging of adenovirus type 5 DNA. J. Virol. 66:1992;723-731.
18. Graham F.L., Smiley J., Russell W.C., Nairu R. Characteristics of a human cell line transformed by DNA from adenovirus type 5. J. Gen. Virol. 36:1977;59-72.
19. Gustin K.E., Imperiale M.J. Encapsidation of viral DNA requires the adenovirus L1 52/55-kilodalton protein. J. Virol. 72:1998;7860-7870.
20. Hammarskjold M.L., Winberg G. Encapsidation of adenovirus 16 DNA is directed by a small DNA sequence at the left end of the genome. Cell. 20:1980;787-795.
21. Hasson T.B., Soloway P.D., Ornelles D.A., Doerfler W., Shenk T. Adenovirus L1 52- and 55-kilodalton proteins are required for assembly of virions. J. Virol. 63:1989;3612-3621.
22. Hearing P., Samulski R.J., Wishart W.L., Shenk T. Identification of a repeated sequence element required for efficient encapsidation of the adenovirus type 5 chromosome. J. Virol. 61:1987;2555-2558.
23. Hearing P., Shenk T. The adenovirus type 5 E1A transcriptional control region contains a duplicated enhancer element. Cell. 33:1983;695-703.
24. Hearing P., Shenk T. The adenovirus type 5 E1A enhancer contains two functionally distinct domains one is specific for E1A and the other modulates all early units in cis . Cell. 45:1986;229-236.
25. Hirahara T., Yasuhara H., Matsui O., Yamanaka M., Tanaka M., Fukuyama S., Izumida A., Yoshiki K., Kodama K., Nakai M., Sasaki N. Isolation of porcine adenovirus from the respiratory tract of pigs in Jpn. J. Vet. Sci. 52:1990;407-409.
26. Kim I.H., Jozkowicz A., Piedra P.A., Oka K., Chan L. Life time correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc. Natl. Acad. Sci. USA. 98:2001;13282-13287.
27. Kosturko L.D., Sharnick S.V., Tibbetts C. Polar encapsidation of adenovirus DNA cloning and DNA sequence of the left end of adenovirus type 3 . J. Virol. 43:1982;1132-1137.
28. Maione D., Wiznerowicz M., Delmastro P., Cortese R., Ciliberto G., Monica N.L.a., Savino R. Prolonged expression and effective readministration of erythropoietin delivered with a fully deleted adenoviral vector. Hum. Gene Ther. 11:2000;859-868.
29. Morral N., O'Neal W., Rice K., Leland M., Kaplan J., Piedra P.A., Zhou H., Parks R.J., Velji R., Aguilar-Córdova E., Wadsworth S., Graham F.L., Kochanek S., Carey K.D., Beaudet A.L. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver directed gene transfer in baboons. Proc. Natl. Acad. Sci. USA. 96:1999;12816-12821.
30. Morral N., Parks R.J., Zhou H., Langston C., Schiedner M., Quinones J., Graham F.L., Kochanek S., Beaudet A.L. High doses of a helper-dependent adenoviral vector yield supraphysiological levels of α1-antitrypsin with negligible toxicity. Hum. Gene Ther. 9:1998;2709-2716.
31. Morsy M.A., Gu M., Motzel S., Zhao J., Lin J., Su Q., Allen H., Franlin L., Parks R.J., Graham F.L., Kochanek S., Bett A.J., Caskey C.T. An adenoviral vector deleted for all viral coding sequences results in enhanced safety and extended expression of a leptin transgene. Proc. Natl. Acad. Sci. USA. 95:1998;7866-7871.
32. Nagy M., Nagy E., Tuboly T. The complete nucleotide sequence of porcine adenovirus serotype 5. J. Gen. Virol. 82:2001;525-529.
33. Ng P., Beauchamp C., Evelegh C., Parks R., Graham F.L. Development of a FLP/frt system for generating helper-dependent adenoviral vectors. Mol. Ther. 3:2001;809-815.
34. Oka K., Pastore L., Kim I.-H., Merched A., Nomura S., Lee H.-J., Merched-Sauvage M., Arden-Riley C., Lee B., Finegold M., Beaudet A., Chan L. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation. 103:2001;1274-1281.
35. Parks R.J., Chen L., Anton M., Sankar U., Rudnicki M.A., Graham F.L. A helper-dependent adenovirus vector system removal of helper virus by Cre-mediated excision of the viral packaging signal . Proc. Natl. Acad. Sci. USA. 93:1996;13565-13570.
36. Reddy P.S., Idamakanti N., Babiuk L.A., Mehtali M., Tikoo S.K. Porcine adenovirus-3 as a helper-dependent expression vector. J. Gen. Virol. 80:1999;2909-2916.
37. Reddy P.S., Idamakanti N., Hyun B.H., Tikoo S.K., Babiuk L.A. Development of porcine adenovirus-3 as an expression vector. J. Gen. Virol. 80:1999;563-570.
38. Reddy P.S., Idamakanti N., Song J.Y., Lee J.B., Hyun B.H., Park J.H., Cha S.H., Bae Y.T., Tikoo S.K., Babiuk L.A. Nucleotide sequence and transcription map of porcine adenovirus type 3. Virology. 251:1998;414-426.
39. Reddy P.S., Idamakanti N., Song J.Y., Lee J.B., Hyun B.H., Park J.H., Cha S.H., Tikoo S.K., Babiuk L.A. Sequence and transcription map analysis of early region-1 of porcine adenovirus type-3. Virus Res. 58:1998;97-106.
40. Robinson C.C., Tibbetts C. Polar encapsidation of adenovirus DNA evolutionary variants reveal dispensable sequences near the left ends of Ad3 genomes . Virology. 137:1984;276-286.
41. Russell W.C. Update on adenovirus and its vectors. J. Gen. Virol. 81:2000;2573-2604.
42. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning A Laboratory Manual . second ed. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
43. Sandig V., Youil R., Bett A.J., Franlin L.L., Oshima M., Maione D., Wang F., Metzker M.L., Savino R., Caskey C.T. Optimization of the helper-dependent adenovirus system for production and potency in vivo. Proc. Natl. Acad. Sci. USA. 97:2000;1002-1007.
44. Schiedner G., Morral N., Parks R.J., Wu Y., Koopmans S.C., Langston C., Graham F.L., Beaudet A.L., Kochanek S. Genomic DNA transfer with a high-capacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18:1998;180-183.
45. Schmid S.I., Hearing P. Selective encapsidation of adenovirus DNA. Curr. Top. Microbiol. Immunol. 199:1995;67-80.
46. Schmid S.I., Hearing P. Bipartite structure and functional independence of adenovirus type 5 packaging elements. J. Virol. 71:1997;3375-3384.
47. Schmid S.I., Hearing P. Cellular components interact with adenovirus type 5 minimal DNA packaging domains. J. Virol. 72:1998;6339-6347.
48. Soudais C., Boutin S., Kremer E.J. Characterization of cis-acting sequences involved in canine adenovirus packaging. Mol. Ther. 3:2001;631-640.
49. Tibbetts C. Viral DNA sequences from incomplete particles of human adenovirus type 7. Cell. 12:1977;243-249.
50. Thomas C.E., Schiedner G., Kochanek S., Castro M.G., Lowenstein P.R. Peripheral infection with adenovirus causes unexpected long-term brain inflammation in animals injected intracranially with first-generation, but not with high-capacity, adenovirus vectors toward realistic long-term neurological gene therapy for chronic diseases . Proc. Natl. Acad. Sci. USA. 97:2000;7482-7487.
51. Umana P., Gerdes C.A., Stone D., Davis J.R.E., Ward D., Castro M.G., Lowenstein P.R. Efficient FLPe recombinase enables scalable production of helper-dependent adenoviral vectors with negligible helper-virus contamination. Nat. Biotechnol. 19:2001;582-585.
52. Zhang W., Imperiale M.J. Interaction of the adenovirus IVa2 protein with viral packaging sequences. J. Virol. 74:2000;2687-2693.
53. Zhang W., Low J.A., Christensen J.B., Imperiale M.J. Role for the adenovirus IVa2 protein in packaging of viral DNA. J. Virol. 75:2001;10446-10454.
54. Zhou H., Zhao T., Pastore L., Nageh M., Zheng W., Rao X.M., Beaudet A.L. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector. Mol. Ther. 3:2001;613-622.
55. Zou L., Yuan X., Zhou H., Lu H., Yang K. Helper-dependent adenoviral vector-mediated gene transfer in aged rat brain. Hum. Gene Ther. 12:2001;181-191.